<bill session="108" type="s" number="303" updated="2023-01-15T22:03:50Z">
  <state datetime="2003-02-05">REFERRED</state>
  <status>
    <introduced datetime="2003-02-05"/>
  </status>
  <introduced datetime="2003-02-05"/>
  <titles>
    <title type="display">Human Cloning Ban and Stem Cell Research Protection Act of 2003</title>
    <title type="official" as="introduced">A bill to prohibit human cloning and protect stem cell research.</title>
    <title type="short" as="introduced">Human Cloning Ban and Stem Cell Research Protection Act of 2003</title>
    <title type="popular">Cloning of Humans bill</title>
  </titles>
  <sponsor bioguide_id="H000338"/>
  <cosponsors>
    <cosponsor bioguide_id="B000711" joined="2003-02-06"/>
    <cosponsor bioguide_id="C001042" joined="2003-03-31"/>
    <cosponsor bioguide_id="D000563" joined="2003-03-20"/>
    <cosponsor bioguide_id="F000062" joined="2003-02-05"/>
    <cosponsor bioguide_id="H000206" joined="2003-02-05"/>
    <cosponsor bioguide_id="J000072" joined="2003-05-15"/>
    <cosponsor bioguide_id="K000105" joined="2003-02-05"/>
    <cosponsor bioguide_id="K000148" joined="2004-07-13"/>
    <cosponsor bioguide_id="L000123" joined="2003-02-06"/>
    <cosponsor bioguide_id="M001141" joined="2003-02-05"/>
    <cosponsor bioguide_id="S000709" joined="2003-02-05"/>
  </cosponsors>
  <actions>
    <action datetime="2003-02-05">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2003-02-05" state="REFERRED">
      <text>Read twice and referred to the Committee on the Judiciary.</text>
    </action>
  </actions>
  <committees>
    <committee code="SSJU" name="Senate Judiciary" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Cloning"/>
    <term name="Congress"/>
    <term name="Congressional oversight"/>
    <term name="Congressional reporting requirements"/>
    <term name="Crime and Law Enforcement"/>
    <term name="Cytology"/>
    <term name="Donation of organs, tissues, etc."/>
    <term name="Ethics"/>
    <term name="Federal-state relations"/>
    <term name="Fines (Penalties)"/>
    <term name="Forfeiture"/>
    <term name="Genetics"/>
    <term name="Government Operations and Politics"/>
    <term name="Human embryology"/>
    <term name="In vitro fertilization"/>
    <term name="International Affairs"/>
    <term name="Laboratories"/>
    <term name="Law"/>
    <term name="Medical research"/>
    <term name="Science, Technology, Communications"/>
    <term name="State laws"/>
  </subjects>
  <amendments/>
  <summary date="2006-11-28T17:35:40Z" status="Introduced in Senate">Human Cloning Ban and Stem Cell Research Protection Act of 2003 - Amends the Federal criminal code to prohibit: (1) conducting or attempting to conduct human cloning; (2) shipping the product of nuclear transplantation for the purpose of human cloning in the United States or elsewhere; or (3) exporting to a foreign country an unfertilized blastocyst if such country does not prohibit human cloning.Requires the Comptroller General to report to the congressional judiciary committees on: (1) actions taken to enforce such prohibitions; (2) actions of State attorneys general to enforce similar State laws; (3) the Federal-State-local government coordination of enforcement actions; and (4) international laws relating to human cloning.Amends the Public Health Service Act to require research involving nuclear transplantation to be conducted in accordance with applicable Federal standards for the protection of human subjects. Prohibits: (1) a somatic cell nucleus from being transplanted into a human oocyte (egg) that has undergone or will undergo fertilization; (2) an unfertilized blastocyst from being maintained after more than 14 days from its first cell division, not counting storage times at temperatures less than zero degrees centigrade; (3) an oocyte from being used in nuclear transplantation research unless donated voluntarily with the donor's informed consent; (4) an oocyte or unfertilized blastocyst from being acquired, received, or transferred for valuable consideration in interstate commerce; or (5) the conduct in a laboratory of nuclear transplantation in which human oocytes are subject to assisted reproductive technology treatments or procedures.</summary>
</bill>
